American Century Companies, Inc., American Century Investment Management, Inc., American Century ETF Trust, and Stowers Institute for Medical Research filed an amended Schedule 13G on November 16, 2026, disclosing beneficial ownership positions in Emergent BioSolutions Inc. common stock as of September 30, 2026.
Key Highlights
- Triggering date: The event requiring this filing occurred on September 30, 2026.
- American Century Companies, Inc. stake: The filing reports 3,312,329 shares beneficially owned, representing 6.5% of the class.
- American Century ETF Trust stake: The filing reports 3,200,942 shares beneficially owned, representing 6.2% of the class.
- Sole voting and dispositive power: All reported shares are held with sole voting power and sole dispositive power; shared voting and shared dispositive power are each reported as 0.
- Corporate structure: According to the filing, American Century Investment Management, Inc. is a wholly-owned subsidiary of American Century Companies, Inc., which is controlled by Stowers Institute for Medical Research.
- Ordinary course certification: The filers certify that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."
American Century Entities Report Positions in Emergent BioSolutions Common Stock
Four affiliated entities filed an amended Schedule 13G with the SEC on November 16, 2026, reporting their beneficial ownership of common stock in Emergent BioSolutions Inc. (NYSE:EBS), headquartered at 300 Professional Dr, Gaithersburg, Maryland 20879. The triggering event date for the amendment is listed as September 30, 2026. The filers are organized in Delaware and share a principal business address of 4500 Main Street, 9th Floor, Kansas City, Missouri 64111.
According to the filing, American Century Investment Management, Inc. (classified as an investment adviser) and American Century Companies, Inc. (classified as a holding company) each report aggregate beneficial ownership of 3,312,329 shares, equal to 6.5% of the class. American Century ETF Trust (classified as an investment company) separately reports 3,200,942 shares, equal to 6.2% of the class. Stowers Institute for Medical Research, identified as a holding company and the controlling entity of American Century Companies, Inc., also reports 3,312,329 shares at 6.5%. In all cases, shared voting power and shared dispositive power are reported as 0.
The filing notes that "various persons, including the investment companies and separate institutional investor accounts" that American Century Investment Management, Inc. serves as investment adviser, have the right to receive dividends from or the proceeds from the sale of the reported securities. The filing further states that no single client advised by American Century Investment Management, Inc. owns more than 5% of the class individually.
What Was Disclosed
Four American Century-affiliated entities filed an amended Schedule 13G disclosing combined beneficial ownership of up to 3,312,329 shares, or 6.5%, of Emergent BioSolutions Inc. common stock, with all voting and dispositive power held on a sole basis as of September 30, 2026.



Please wait processing your request...